ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

B3K Ackermans and Van Haaren NV

194.10
-1.20 (-0.61%)
10 Jan 2025 - Closed
Realtime Data
Share Name Share Symbol Market Type
Ackermans and Van Haaren NV TG:B3K Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.20 -0.61% 194.10 194.00 194.10 194.10 194.10 194.10 138 20:59:59

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

26/07/2024 6:00am

UK Regulatory


Ackermans and Van Haaren... (TG:B3K)
Historical Stock Chart


From Jul 2024 to Jan 2025

Click Here for more Ackermans and Van Haaren... Charts.
Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

Dear shareholder,

Dear Madam, Dear Sir,


please find attached our press release.


Best regards

Ackermans & van Haaren

Attachment

  • Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics (press release 26 July 2024)

1 Year Ackermans and Van Haaren... Chart

1 Year Ackermans and Van Haaren... Chart

1 Month Ackermans and Van Haaren... Chart

1 Month Ackermans and Van Haaren... Chart

Your Recent History

Delayed Upgrade Clock